Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Anebulo Pharmaceuticals, Inc. (ANEB)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 |
| Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -372.1% | -282.6% | |
ROIC (including intangibles) | -548.3% | -149.0% | -131.2% |
ROE | -45.3% | -16.9% | -6.2% |
ROA | -43.8% | -16.7% | -5.7% |
|
Cash Conversion Cycle |
Days sales outstanding | | | 8.5 |
Cash conversion cycle | | | 8.5 |
|